Abstract
Progress in cancer research continues to advance rapidly, with significant developments in understanding the genetic basis of cancer, identification of new cancer-associated genes, and the development of targeted therapies based on genetic profiling. Advances are accelerating on many fronts due in large part to increased robustness of high throughput technologies and improvements in biospecimen acquisition and management. Notable key areas of progress in cancer genetics include cancer genomics, liquid biopsies, immunotherapy and biomarkers, precision medicine and cancer risk assessment.Progress in cancer research continues to advance rapidly, with significant developments in understanding the genetic basis of cancer, identification of new cancer-associated genes, and the development of targeted therapies based on genetic profiling. Advances are accelerating on many fronts due in large part to increased robustness of high throughput technologies and improvements in biospecimen acquisition and management. Notable key areas of progress in cancer genetics include cancer genomics, liquid biopsies, immunotherapy and biomarkers, precision medicine and cancer risk assessment.
| Original language | English |
|---|---|
| Pages (from-to) | N/A-N/A |
| Journal | Frontiers in Oncology |
| Volume | 13 |
| Issue number | 13 |
| DOIs | |
| Publication status | Published - 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Oncology
- Cancer Research
Keywords
- cancer genetics
- genomics
- immunotherapy
- neoantigens
- prognosis biomarkers
Fingerprint
Dive into the research topics of 'Editorial: 365 days of progress in cancer genetics'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver